A new combined cancer chemotherapy regimen of mitomycin C (MMC) and cisplatin (DDP) showed synergistic antitumor activity against human gastric cancer xenografts St-40 and SC-1-NU in BALB/c nu/nu mice. The drugs were administered intraperitoneally at doses of 2 or 4 mg/kg for MMC and 3 or 6 mg/kg fo
Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts
✍ Scribed by Yoshifumi Takei; Kenji Kadomatsu; Tatsunori Goto; Takashi Muramatsu
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 672 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract HER2 represents an important signaling pathway in breast and other cancers. Herceptin has demonstrated clinical activity, but resistance is common. Thus, new therapeutic approaches to the HER2 pathway are needed. Grb2 is an adaptor protein involved in Ras‐dependent signaling induced by
BACKGROUND. The specific paclitaxel dose or time course in the treatment of colon carcinoma without the disruption of normal colonic cell proliferation is currently not known. The aim of this study was to determine the effects of paclitaxel on the growth of human colonic epithelial cells using cultu
## Abstract Nude mice bearing xenografts of the androgen‐independent human prostate‐cancer cell line PC‐3 were treated for 4 weeks with somatostatin analog RC‐160, bombesin/gastrin‐releasing peptide (GRP) antagonist (RC‐3095), or the combination of both peptides. In the first experiment, treatment
## Abstract Our previous studies indicated that cyclooxygenase‐2 inhibitor or octreotide could suppress the proliferation of gastric adenocarcinoma __in vitro__ or __in vivo__. The present study was aimed to find whether rofecoxib combined with octreotide could enhance the inhibitive effects on the